Gallery
- Karnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)Wedding pics: Mouni Roy marries Suraj Nambiar in South Indian ceremony73rd Republic Day Parade 2022 - In Pictures
First Serve, an NGO founded by Reyaan Punj, recently organised the second edition of AITA
- Bajrang Punia provisionally suspended by NADA, Paris berth at stake: Sources
- Laureus Award 2024 : Novak Djokovic, Aitana Bonmati win top honours at Laureus Sports Awards
- Asian Games medallist Jyothi Yarraji to train in Spain ahead of Paris Olympics
- Lione Messi said Retirement not on my mind
- Indian Wells: Alcaraz, Swiatek win titles
'Antibody cocktail' therapy used for Covid patient in Punjab Last Updated : 30 May 2021 11:10:41 PM IST The 'antibody cocktail' therapy was administered to a 72-year-old Covid positive patient who is a diabetic with chronic kidney disease, at the Fortis Hospital here on Sunday.
Administered one dose of the cocktail intravenously, the patient is reportedly stable post infusion, said the Fortis Hospital.The 'antibody cocktail therapy' is for those above the age of 65, who are isolating at home, have a saturation oxygen of 93, require no oxygen support but are at risk of developing a severe form of the infection on account of their co-morbidities such as obesity, diabetes, liver disease, heart ailments, or chronic lung disease.It can also be administered to those suffering from an immuno-compromising condition or those with weakened immunity on account of immune suppressive treatment.Dr Zafar Ahmed, Senior Consultant - Critical Care, Pulmonology and Chest and Sleep Medicine in Fortis Hospital, said like antibodies, which are proteins generated by the body to fight disease, monoclonal antibodies are "artificially created in the lab".In this cocktail, Casirivimab and Imdevimab are monoclonal antibodies that specifically block the spike protein of SARS-CoV-2, thereby preventing the coronavirus attachment and entry into human cells.As much as 600 grams of each are mixed forming the cocktail. This is another very important step that has been taken by the medical community to effectively combat the pandemic and help people recover faster.Fortis on Saturday announced that two doses of Roche India's antibody cocktail (Casirivimab and Imdevimab) distributed by Cipla Ltd is available for administration to patients with mild and moderate Covid-19 infection.Launched on May 24 in India by Roche India, the antibody cocktail has received emergency use authorization from the Central Drugs Standards Control Organisation.IANS Mohali For Latest Updates Please-
Join us on
Follow us on
172.31.16.186